Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial—PROSPECT: protocol for a feasibility randomized pilot trial View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-05-24

AUTHORS

Jennie Johnstone, Maureen Meade, John Marshall, Daren K Heyland, Michael G Surette, Dawn ME Bowdish, Francois Lauzier, Lehana Thebane, Deborah J Cook,

ABSTRACT

BACKGROUND: Probiotics are defined as live microorganisms that may confer health benefits when ingested. Meta-analysis of probiotic trials suggests a 25 % lower ventilator-associated pneumonia (VAP) and 18 % lower infection rates overall when administered to patients in the intensive care unit (ICU). However, prior trials are small, largely single center, and at high risk of bias. Before a large rigorous trial is launched, testing whether probiotics confer benefit, harm, or have no impact, a pilot trial is needed. The aim of the PROSPECT Pilot Trial is to determine the feasibility of performing a larger trial in mechanically ventilated critically ill patients investigating Lactobacillus rhamnosus GG. A priori, we determined that the feasibility of the larger trial would be based on timely recruitment, high protocol adherence, minimal contamination, and an acceptable VAP rate. METHODS/DESIGN: Patients ≥18 years old in the ICU who are anticipated to receive mechanical ventilation for ≥72 hours will be included. Patients are excluded if they are at increased risk of probiotic-associated infection, have strict enteral medication contraindications, are pregnant, previously enrolled in a related trial, or are receiving palliative care. Following informed consent, patients are randomized in variable unspecified block sizes in a fixed 1:1 ratio, stratified by ICU, and medical, surgical, or trauma admitting diagnosis. Patients receive 1 × 1010 colony forming units of L. rhamnosus GG (Culturelle, Locin Industries Ltd) or an identical placebo suspended in tap water administered twice daily via nasogastric tube in the ICU. Clinical and research staff, patients, and families are blinded. DISCUSSION: The primary outcomes for this pilot trial are the following: (1) recruitment success, (2) ≥90 % protocol adherence, (3) ≤5 % contamination, and (4) ~10 % VAP rate. Additional clinical outcomes are VAP, other infections, diarrhea (total, antibiotic associated, and Clostridium difficile), ICU and hospital length of stay, and mortality. The morbidity, mortality, and cost of VAP underscore the need for cost-effective prophylactic interventions. The PROSPECT Pilot Trial is the initial step toward rigorously evaluating whether probiotics decrease nosocomial infections, have no effect, or actually cause infections in critically ill patients. TRIAL REGISTRATION: ClinicalTrials.gov. NCT01782755. More... »

PAGES

19

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s40814-015-0013-3

DOI

http://dx.doi.org/10.1186/s40814-015-0013-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1037826788

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27965798


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medicine, University of Toronto, Toronto, Canada", 
          "id": "http://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Public Health Ontario, Toronto, Ontario Canada", 
            "St. Joseph\u2019s Health Center, Toronto, Ontario Canada", 
            "Department of Medicine, University of Toronto, Toronto, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Johnstone", 
        "givenName": "Jennie", 
        "id": "sg:person.0710523652.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0710523652.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Canada", 
          "id": "http://www.grid.ac/institutes/grid.25073.33", 
          "name": [
            "Department of Medicine, McMaster Health Sciences Center, Room 2C11, 1200 Main Street W, Hamilton, Ontario Canada", 
            "Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Meade", 
        "givenName": "Maureen", 
        "id": "sg:person.01316617337.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316617337.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Interdepartmental Division of Critical Care, University of Toronto, Toronto, Canada", 
          "id": "http://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Department of Medicine, University of Toronto, Toronto, Canada", 
            "Department of Surgery, University of Toronto, Toronto, Canada", 
            "Interdepartmental Division of Critical Care, University of Toronto, Toronto, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Marshall", 
        "givenName": "John", 
        "id": "sg:person.01064471126.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064471126.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Queen\u2019s University, Kingston, Canada", 
          "id": "http://www.grid.ac/institutes/grid.410356.5", 
          "name": [
            "Department of Medicine, Queen\u2019s University, Kingston, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Heyland", 
        "givenName": "Daren K", 
        "id": "sg:person.01025111410.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025111410.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, McMaster Health Sciences Center, Room 2C11, 1200 Main Street W, Hamilton, Ontario Canada", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Medicine, McMaster Health Sciences Center, Room 2C11, 1200 Main Street W, Hamilton, Ontario Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Surette", 
        "givenName": "Michael G", 
        "id": "sg:person.01237160221.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01237160221.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pathology and Molecular Medicine, McMaster University, Hamilton, Canada", 
          "id": "http://www.grid.ac/institutes/grid.25073.33", 
          "name": [
            "Pathology and Molecular Medicine, McMaster University, Hamilton, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bowdish", 
        "givenName": "Dawn ME", 
        "id": "sg:person.01201465765.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201465765.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Research Center of the CHU de Qu\u00e9bec, Population Health and Optimal Health Practices Research Unit, Qu\u00e9bec, Canada", 
          "id": "http://www.grid.ac/institutes/grid.411081.d", 
          "name": [
            "Department of Medicine, Research Center of the CHU de Qu\u00e9bec, Population Health and Optimal Health Practices Research Unit, Qu\u00e9bec, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lauzier", 
        "givenName": "Francois", 
        "id": "sg:person.01066142337.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066142337.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Biostatistics Unit, St Joseph\u2019s Healthcare\u2014Hamilton, Hamilton, Ontario Canada", 
          "id": "http://www.grid.ac/institutes/grid.416721.7", 
          "name": [
            "Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Canada", 
            "Biostatistics Unit, St Joseph\u2019s Healthcare\u2014Hamilton, Hamilton, Ontario Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thebane", 
        "givenName": "Lehana", 
        "id": "sg:person.015137421525.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015137421525.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Canada", 
          "id": "http://www.grid.ac/institutes/grid.25073.33", 
          "name": [
            "Department of Medicine, McMaster Health Sciences Center, Room 2C11, 1200 Main Street W, Hamilton, Ontario Canada", 
            "Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cook", 
        "givenName": "Deborah J", 
        "id": "sg:person.01372124736.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372124736.59"
        ], 
        "type": "Person"
      }, 
      {}
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1471-2288-10-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032642219", 
          "https://doi.org/10.1186/1471-2288-10-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00134-013-3074-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015076157", 
          "https://doi.org/10.1007/s00134-013-3074-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/cc11917", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031299154", 
          "https://doi.org/10.1186/cc11917"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-05-24", 
    "datePublishedReg": "2015-05-24", 
    "description": "BACKGROUND: Probiotics are defined as live microorganisms that may confer health benefits when ingested. Meta-analysis of probiotic trials suggests a 25\u00a0% lower ventilator-associated pneumonia (VAP) and 18\u00a0% lower infection rates overall when administered to patients in the intensive care unit (ICU). However, prior trials are small, largely single center, and at high risk of bias. Before a large rigorous trial is launched, testing whether probiotics confer benefit, harm, or have no impact, a pilot trial is needed. The aim of the PROSPECT Pilot Trial is to determine the feasibility of performing a larger trial in mechanically ventilated critically ill patients investigating Lactobacillus rhamnosus GG. A priori, we determined that the feasibility of the larger trial would be based on timely recruitment, high protocol adherence, minimal contamination, and an acceptable VAP rate.\nMETHODS/DESIGN: Patients \u226518\u00a0years old in the ICU who are anticipated to receive mechanical ventilation for \u226572\u00a0hours will be included. Patients are excluded if they are at increased risk of probiotic-associated infection, have strict enteral medication contraindications, are pregnant, previously enrolled in a related trial, or are receiving palliative care. Following informed consent, patients are randomized in variable unspecified block sizes in a fixed 1:1 ratio, stratified by ICU, and medical, surgical, or trauma admitting diagnosis. Patients receive 1\u2009\u00d7\u20091010 colony forming units of L. rhamnosus GG (Culturelle, Locin Industries Ltd) or an identical placebo suspended in tap water administered twice daily via nasogastric tube in the ICU. Clinical and research staff, patients, and families are blinded.\nDISCUSSION: The primary outcomes for this pilot trial are the following: (1) recruitment success, (2) \u226590\u00a0% protocol adherence, (3) \u22645\u00a0% contamination, and (4) ~10\u00a0% VAP rate. Additional clinical outcomes are VAP, other infections, diarrhea (total, antibiotic associated, and Clostridium difficile), ICU and hospital length of stay, and mortality. The morbidity, mortality, and cost of VAP underscore the need for cost-effective prophylactic interventions. The PROSPECT Pilot Trial is the initial step toward rigorously evaluating whether probiotics decrease nosocomial infections, have no effect, or actually cause infections in critically ill patients.\nTRIAL REGISTRATION: ClinicalTrials.gov. NCT01782755.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s40814-015-0013-3", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1053109", 
        "issn": [
          "2055-5784"
        ], 
        "name": "Pilot and Feasibility Studies", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "1"
      }
    ], 
    "keywords": [
      "intensive care unit", 
      "ventilator-associated pneumonia", 
      "pilot trial", 
      "VAP rates", 
      "ill patients", 
      "large trials", 
      "protocol adherence", 
      "Larger rigorous trials", 
      "high protocol adherence", 
      "additional clinical outcomes", 
      "low infection rate", 
      "medication contraindications", 
      "identical placebo", 
      "hospital length", 
      "primary outcome", 
      "clinical outcomes", 
      "care unit", 
      "single center", 
      "mechanical ventilation", 
      "severe pneumonia", 
      "palliative care", 
      "nasogastric tube", 
      "prophylactic interventions", 
      "rigorous trials", 
      "nosocomial infections", 
      "high risk", 
      "patients", 
      "probiotic trials", 
      "infection rate", 
      "prior trials", 
      "infection", 
      "informed consent", 
      "trials", 
      "health benefits", 
      "live microorganisms", 
      "confer benefits", 
      "related trials", 
      "pneumonia", 
      "research staff", 
      "mortality", 
      "timely recruitment", 
      "adherence", 
      "probiotics", 
      "outcomes", 
      "risk", 
      "placebo", 
      "contraindications", 
      "morbidity", 
      "diarrhea", 
      "stay", 
      "trauma", 
      "diagnosis", 
      "prevention", 
      "care", 
      "GG", 
      "ventilation", 
      "intervention", 
      "rate", 
      "consent", 
      "benefits", 
      "hours", 
      "minimal contamination", 
      "Lactobacillus", 
      "aim", 
      "initial step", 
      "harm", 
      "years", 
      "staff", 
      "tap water", 
      "recruitment", 
      "feasibility", 
      "center", 
      "units", 
      "effect", 
      "need", 
      "family", 
      "contamination", 
      "ratio", 
      "bias", 
      "impact", 
      "success", 
      "tube", 
      "length", 
      "colonies", 
      "microorganisms", 
      "size", 
      "cost", 
      "step", 
      "recruitment success", 
      "block size", 
      "water", 
      "lower ventilator-associated pneumonia", 
      "probiotics confer benefit", 
      "PROSPECT Pilot Trial", 
      "acceptable VAP rate", 
      "probiotic-associated infection", 
      "strict enteral medication contraindications", 
      "enteral medication contraindications", 
      "variable unspecified block sizes", 
      "unspecified block sizes", 
      "cost of VAP", 
      "cost-effective prophylactic interventions", 
      "Endotracheal Colonization Trial\u2014PROSPECT", 
      "Colonization Trial\u2014PROSPECT", 
      "Trial\u2014PROSPECT"
    ], 
    "name": "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: protocol for a feasibility randomized pilot trial", 
    "pagination": "19", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1037826788"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s40814-015-0013-3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27965798"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s40814-015-0013-3", 
      "https://app.dimensions.ai/details/publication/pub.1037826788"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:26", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_679.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s40814-015-0013-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40814-015-0013-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40814-015-0013-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40814-015-0013-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40814-015-0013-3'


 

This table displays all metadata directly associated to this object as RDF triples.

264 TRIPLES      22 PREDICATES      135 URIs      123 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s40814-015-0013-3 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 anzsrc-for:1117
4 schema:author N595edef6fc35478cb6674dacb303ad7e
5 schema:citation sg:pub.10.1007/s00134-013-3074-x
6 sg:pub.10.1186/1471-2288-10-1
7 sg:pub.10.1186/cc11917
8 schema:datePublished 2015-05-24
9 schema:datePublishedReg 2015-05-24
10 schema:description BACKGROUND: Probiotics are defined as live microorganisms that may confer health benefits when ingested. Meta-analysis of probiotic trials suggests a 25 % lower ventilator-associated pneumonia (VAP) and 18 % lower infection rates overall when administered to patients in the intensive care unit (ICU). However, prior trials are small, largely single center, and at high risk of bias. Before a large rigorous trial is launched, testing whether probiotics confer benefit, harm, or have no impact, a pilot trial is needed. The aim of the PROSPECT Pilot Trial is to determine the feasibility of performing a larger trial in mechanically ventilated critically ill patients investigating <i>Lactobacillus rhamnosus</i> GG. A priori, we determined that the feasibility of the larger trial would be based on timely recruitment, high protocol adherence, minimal contamination, and an acceptable VAP rate. METHODS/DESIGN: Patients ≥18 years old in the ICU who are anticipated to receive mechanical ventilation for ≥72 hours will be included. Patients are excluded if they are at increased risk of probiotic-associated infection, have strict enteral medication contraindications, are pregnant, previously enrolled in a related trial, or are receiving palliative care. Following informed consent, patients are randomized in variable unspecified block sizes in a fixed 1:1 ratio, stratified by ICU, and medical, surgical, or trauma admitting diagnosis. Patients receive 1 × 10<sup>10</sup> colony forming units of <i>L. rhamnosus</i> GG (Culturelle, Locin Industries Ltd) or an identical placebo suspended in tap water administered twice daily via nasogastric tube in the ICU. Clinical and research staff, patients, and families are blinded. DISCUSSION: The primary outcomes for this pilot trial are the following: (1) recruitment success, (2) ≥90 % protocol adherence, (3) ≤5 % contamination, and (4) ~10 % VAP rate. Additional clinical outcomes are VAP, other infections, diarrhea (total, antibiotic associated, and Clostridium difficile), ICU and hospital length of stay, and mortality. The morbidity, mortality, and cost of VAP underscore the need for cost-effective prophylactic interventions. The PROSPECT Pilot Trial is the initial step toward rigorously evaluating whether probiotics decrease nosocomial infections, have no effect, or actually cause infections in critically ill patients. TRIAL REGISTRATION: ClinicalTrials.gov. NCT01782755.
11 schema:genre article
12 schema:inLanguage en
13 schema:isAccessibleForFree true
14 schema:isPartOf N3ded7168ceb74b2fa9022d2193ceaf1b
15 Nb166f83c73ef4476a33a4e20b1a9e667
16 sg:journal.1053109
17 schema:keywords Colonization Trial—PROSPECT
18 Endotracheal Colonization Trial—PROSPECT
19 GG
20 Lactobacillus
21 Larger rigorous trials
22 PROSPECT Pilot Trial
23 Trial—PROSPECT
24 VAP rates
25 acceptable VAP rate
26 additional clinical outcomes
27 adherence
28 aim
29 benefits
30 bias
31 block size
32 care
33 care unit
34 center
35 clinical outcomes
36 colonies
37 confer benefits
38 consent
39 contamination
40 contraindications
41 cost
42 cost of VAP
43 cost-effective prophylactic interventions
44 diagnosis
45 diarrhea
46 effect
47 enteral medication contraindications
48 family
49 feasibility
50 harm
51 health benefits
52 high protocol adherence
53 high risk
54 hospital length
55 hours
56 identical placebo
57 ill patients
58 impact
59 infection
60 infection rate
61 informed consent
62 initial step
63 intensive care unit
64 intervention
65 large trials
66 length
67 live microorganisms
68 low infection rate
69 lower ventilator-associated pneumonia
70 mechanical ventilation
71 medication contraindications
72 microorganisms
73 minimal contamination
74 morbidity
75 mortality
76 nasogastric tube
77 need
78 nosocomial infections
79 outcomes
80 palliative care
81 patients
82 pilot trial
83 placebo
84 pneumonia
85 prevention
86 primary outcome
87 prior trials
88 probiotic trials
89 probiotic-associated infection
90 probiotics
91 probiotics confer benefit
92 prophylactic interventions
93 protocol adherence
94 rate
95 ratio
96 recruitment
97 recruitment success
98 related trials
99 research staff
100 rigorous trials
101 risk
102 severe pneumonia
103 single center
104 size
105 staff
106 stay
107 step
108 strict enteral medication contraindications
109 success
110 tap water
111 timely recruitment
112 trauma
113 trials
114 tube
115 units
116 unspecified block sizes
117 variable unspecified block sizes
118 ventilation
119 ventilator-associated pneumonia
120 water
121 years
122 schema:name Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial—PROSPECT: protocol for a feasibility randomized pilot trial
123 schema:pagination 19
124 schema:productId N8c4fba57b9454ac5b04034b89513aa09
125 N99488baf2e3f4ee79d09d39a854bd0fe
126 Nca44d44efd15438bb9b13a0e2d64fe69
127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037826788
128 https://doi.org/10.1186/s40814-015-0013-3
129 schema:sdDatePublished 2021-11-01T18:26
130 schema:sdLicense https://scigraph.springernature.com/explorer/license/
131 schema:sdPublisher Nf5182d71d68c46e8a8affcbde91593da
132 schema:url https://doi.org/10.1186/s40814-015-0013-3
133 sgo:license sg:explorer/license/
134 sgo:sdDataset articles
135 rdf:type schema:ScholarlyArticle
136 N27a3e63db9494163a832644dd6a8fae1 rdf:first sg:person.01201465765.19
137 rdf:rest Nd8f10eaa3c9640aba6c4ac72aa6428ab
138 N2aad9fb5a6de4781b44911bd5f98fcb6 rdf:first sg:person.01372124736.59
139 rdf:rest N899d02e3fba747e5b4507e5236606c1a
140 N3ded7168ceb74b2fa9022d2193ceaf1b schema:volumeNumber 1
141 rdf:type schema:PublicationVolume
142 N595edef6fc35478cb6674dacb303ad7e rdf:first sg:person.0710523652.20
143 rdf:rest Nd68444f150d04391912991e215140496
144 N827d1d2547c54220b0bf5b5ac1264c61 rdf:first sg:person.01237160221.29
145 rdf:rest N27a3e63db9494163a832644dd6a8fae1
146 N899d02e3fba747e5b4507e5236606c1a rdf:first N511a4ce92aa2486483a651602511b077
147 rdf:rest rdf:nil
148 N8c4fba57b9454ac5b04034b89513aa09 schema:name doi
149 schema:value 10.1186/s40814-015-0013-3
150 rdf:type schema:PropertyValue
151 N99488baf2e3f4ee79d09d39a854bd0fe schema:name pubmed_id
152 schema:value 27965798
153 rdf:type schema:PropertyValue
154 Na0c46fef1b2c4467a37c60f87b1c3b02 rdf:first sg:person.01064471126.24
155 rdf:rest Nb31cbcb4bd2948d983df5121d830b3fe
156 Nb0a8c65898fa416dbd5e1bc09c9f7d0a rdf:first sg:person.015137421525.05
157 rdf:rest N2aad9fb5a6de4781b44911bd5f98fcb6
158 Nb166f83c73ef4476a33a4e20b1a9e667 schema:issueNumber 1
159 rdf:type schema:PublicationIssue
160 Nb31cbcb4bd2948d983df5121d830b3fe rdf:first sg:person.01025111410.85
161 rdf:rest N827d1d2547c54220b0bf5b5ac1264c61
162 Nca44d44efd15438bb9b13a0e2d64fe69 schema:name dimensions_id
163 schema:value pub.1037826788
164 rdf:type schema:PropertyValue
165 Nd68444f150d04391912991e215140496 rdf:first sg:person.01316617337.49
166 rdf:rest Na0c46fef1b2c4467a37c60f87b1c3b02
167 Nd8f10eaa3c9640aba6c4ac72aa6428ab rdf:first sg:person.01066142337.60
168 rdf:rest Nb0a8c65898fa416dbd5e1bc09c9f7d0a
169 Nf5182d71d68c46e8a8affcbde91593da schema:name Springer Nature - SN SciGraph project
170 rdf:type schema:Organization
171 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
172 schema:name Medical and Health Sciences
173 rdf:type schema:DefinedTerm
174 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
175 schema:name Clinical Sciences
176 rdf:type schema:DefinedTerm
177 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
178 schema:name Public Health and Health Services
179 rdf:type schema:DefinedTerm
180 sg:journal.1053109 schema:issn 2055-5784
181 schema:name Pilot and Feasibility Studies
182 schema:publisher Springer Nature
183 rdf:type schema:Periodical
184 sg:person.01025111410.85 schema:affiliation grid-institutes:grid.410356.5
185 schema:familyName Heyland
186 schema:givenName Daren K
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025111410.85
188 rdf:type schema:Person
189 sg:person.01064471126.24 schema:affiliation grid-institutes:grid.17063.33
190 schema:familyName Marshall
191 schema:givenName John
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064471126.24
193 rdf:type schema:Person
194 sg:person.01066142337.60 schema:affiliation grid-institutes:grid.411081.d
195 schema:familyName Lauzier
196 schema:givenName Francois
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066142337.60
198 rdf:type schema:Person
199 sg:person.01201465765.19 schema:affiliation grid-institutes:grid.25073.33
200 schema:familyName Bowdish
201 schema:givenName Dawn ME
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201465765.19
203 rdf:type schema:Person
204 sg:person.01237160221.29 schema:affiliation grid-institutes:None
205 schema:familyName Surette
206 schema:givenName Michael G
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01237160221.29
208 rdf:type schema:Person
209 sg:person.01316617337.49 schema:affiliation grid-institutes:grid.25073.33
210 schema:familyName Meade
211 schema:givenName Maureen
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316617337.49
213 rdf:type schema:Person
214 sg:person.01372124736.59 schema:affiliation grid-institutes:grid.25073.33
215 schema:familyName Cook
216 schema:givenName Deborah J
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372124736.59
218 rdf:type schema:Person
219 sg:person.015137421525.05 schema:affiliation grid-institutes:grid.416721.7
220 schema:familyName Thebane
221 schema:givenName Lehana
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015137421525.05
223 rdf:type schema:Person
224 sg:person.0710523652.20 schema:affiliation grid-institutes:grid.17063.33
225 schema:familyName Johnstone
226 schema:givenName Jennie
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0710523652.20
228 rdf:type schema:Person
229 sg:pub.10.1007/s00134-013-3074-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1015076157
230 https://doi.org/10.1007/s00134-013-3074-x
231 rdf:type schema:CreativeWork
232 sg:pub.10.1186/1471-2288-10-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032642219
233 https://doi.org/10.1186/1471-2288-10-1
234 rdf:type schema:CreativeWork
235 sg:pub.10.1186/cc11917 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031299154
236 https://doi.org/10.1186/cc11917
237 rdf:type schema:CreativeWork
238 grid-institutes:None schema:alternateName Department of Medicine, McMaster Health Sciences Center, Room 2C11, 1200 Main Street W, Hamilton, Ontario Canada
239 schema:name Department of Medicine, McMaster Health Sciences Center, Room 2C11, 1200 Main Street W, Hamilton, Ontario Canada
240 rdf:type schema:Organization
241 grid-institutes:grid.17063.33 schema:alternateName Department of Medicine, University of Toronto, Toronto, Canada
242 Interdepartmental Division of Critical Care, University of Toronto, Toronto, Canada
243 schema:name Department of Medicine, University of Toronto, Toronto, Canada
244 Department of Surgery, University of Toronto, Toronto, Canada
245 Interdepartmental Division of Critical Care, University of Toronto, Toronto, Canada
246 Public Health Ontario, Toronto, Ontario Canada
247 St. Joseph’s Health Center, Toronto, Ontario Canada
248 rdf:type schema:Organization
249 grid-institutes:grid.25073.33 schema:alternateName Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Canada
250 Pathology and Molecular Medicine, McMaster University, Hamilton, Canada
251 schema:name Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Canada
252 Department of Medicine, McMaster Health Sciences Center, Room 2C11, 1200 Main Street W, Hamilton, Ontario Canada
253 Pathology and Molecular Medicine, McMaster University, Hamilton, Canada
254 rdf:type schema:Organization
255 grid-institutes:grid.410356.5 schema:alternateName Department of Medicine, Queen’s University, Kingston, Canada
256 schema:name Department of Medicine, Queen’s University, Kingston, Canada
257 rdf:type schema:Organization
258 grid-institutes:grid.411081.d schema:alternateName Department of Medicine, Research Center of the CHU de Québec, Population Health and Optimal Health Practices Research Unit, Québec, Canada
259 schema:name Department of Medicine, Research Center of the CHU de Québec, Population Health and Optimal Health Practices Research Unit, Québec, Canada
260 rdf:type schema:Organization
261 grid-institutes:grid.416721.7 schema:alternateName Biostatistics Unit, St Joseph’s Healthcare—Hamilton, Hamilton, Ontario Canada
262 schema:name Biostatistics Unit, St Joseph’s Healthcare—Hamilton, Hamilton, Ontario Canada
263 Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Canada
264 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...